PRE-FUNDED COMMON STOCK PURCHASE WARRANT TENAX THERAPEUTICS, INC.Tenax Therapeutics, Inc. • May 20th, 2022 • Pharmaceutical preparations
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above as the Initial Exercise Date (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Tenax Therapeutics, Inc., a Delaware corporation (the “Company”), up to ________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 20th, 2022 • Tenax Therapeutics, Inc. • Pharmaceutical preparations
This Agreement is made pursuant to the Securities Purchase Agreement for Units, dated as of the date hereof, between the Company and the Purchaser (the “Purchase Agreement”).
SECURITIES PURCHASE AGREEMENT FOR UNITSSecurities Purchase Agreement for Units • May 20th, 2022 • Tenax Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement for Units (this “Agreement”) is dated as of May 17, 2022, between Tenax Therapeutics, Inc., a Delaware corporation (the “Company”), and Armistice Capital Master Fund Ltd. (including its successors and assigns, the “Purchaser”).
Armistice Capital Master Fund Ltd. c/o Armistice Capital, LLCTenax Therapeutics, Inc. • May 20th, 2022 • Pharmaceutical preparations
